Calcium-sensing receptor mutations and denaturing high performance liquid chromatography

Journal of Molecular Endocrinology

Volumn 42, Issue 4, 2009, Pages 331-339

  Cole, David E C ^a   Yun, Francisco H J ^a   Wong, Betty Y L ^a   Shuen, Andrew Y ^a   Booth, Ronald A ^a   Scillitani, Alfredo ^b   Pidasheva, Svetlana ^c   Zhou, Xiang ^c   Canaff, Lucie ^c   Hendy, Geoffrey N ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM SENSING RECEPTOR; MUTANT PROTEIN;

AMPLICON; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA SEQUENCE; EXON; FAMILIAL DISEASE; GENE MUTATION; HIGH THROUGHPUT SCREENING; HUMAN; HYPERCALCEMIA; HYPOCALCIURIA; INTRON; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; BIOLOGY; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN GENOME; METHODOLOGY; MUTATION; REPRODUCIBILITY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPUTATIONAL BIOLOGY; DNA MUTATIONAL ANALYSIS; EXONS; GENOME, HUMAN; HUMANS; MUTANT PROTEINS; MUTATION; MUTATION, MISSENSE; RECEPTORS, CALCIUM-SENSING; REPRODUCIBILITY OF RESULTS;

EID: 67449156242     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-08-0164     Document Type: Article

References (42)

1. Alvarez-Hernandez D, Santamaria I, Rodriguez-Garcia M, Iglesias P, Delgado-Lillo R & Cannata-Andia JB 2003 A novel mutation in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia in a family with two uncommon parathyroid hormone polymorphisms. Journal of Molecular Endocrinology 31 255-262.
2. Arunchaiva S, Pollak MR, Seidman CA, Pinhas-Hamiel O, Welch TR, Tsang RC & Smith EP 1998 Marked hypercalcemia in a five-month-old male associated with heterozygous point mutation in the calcium-sensing receptor gene. Program and Abstracts of the 80th Annual Meeting of the Endocrinology Society P3-535 495.
3. 2+o-sensing receptor. Journal of Biological Chemistry 271 19537-19545.
4. Brown EM 2007 Clinical lessons from the calcium-sensing receptor. Nature Clinical Practice. Endocrinology & Metabolism 3 122-133.
5. Burski K, Torjussen B, Paulsen AQ & Bollerslev J 2002 Parathyroid adenona in a subject with familial hypocalciuric hypercalcemia: coincidence or causality? Journal of Clinical Endocrinology and Metabolism 87 1015-1016.
6. Canaff L & Hendy GN 2002 Human calcium-sensing receptor gene: vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. Journal of Biological Chemistry 277 30337-30350.
7. Chikatsu N, Fukumoto S, Takeuchi Y, Suzawa M, Obara T, Matsumoto T & Fujita T 2000 Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas. Journal of Biological Chemistry 275 7553-7557.
8. Cole DEC, Peltekova VD, Rubin LA, Hawker GA, Vieth R, Liew CC, Hwang DM, Evrovski J & Hendy GN 1999 A986S, polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 353 112-115.
9. Cole DEC, Vieth R, Trang HM, Wong BY-L, Hendy GN & Rubin LA 2001 Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Molecular Genetics and Metabolism 72 168-174.
10. Crépin M, Pigny P, Escande F, Bauters CC, Calender A, Lefevre S, Buisine M-P, Porchet N & Odou M-F 2006 Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene. Journal of Molecular Endocrinology 36 369-376.
11. Dreimane D, Hendy GN, Alon U & Geffner M 2001 Normalization of serum calcium, phosphorus, and magnesium with homeopathic PTH in a child with hypocalcemic hypercalciuria (HCHC) and a mutation of the calcium-sensing receptor gene. Program and Abstracts of the 80th Annual Meeting of the Endocrinology Society P3-125 475.
12. D'Souza-Li L, Yang B, Canaff L, Bai M, Hanley DA, Bastepe M, Salisbury SR, Brown EM, Cole DEC & Hendy GN 2002 Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. Journal of Clinical Endocrinology and Metabolism 87 1309-1318.
13. Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, Nemeth EF & Fuller F 1995 Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. Journal of Biological Chemistry 270 12919-12925.
14. Gerhardus A, Schleberger H, Schlegelberger B & Gadzicki D 2007 Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. European Journal of Human Genetics 15 619-627.
15. Guarnieri V, Scillitani A, Battista C, Muscarella LA, Coco M, D'Agruma L, Sacco M, Canaff L, Yun F, Wong BYL, Hendy GN & Cole DEC 2008 Molecular diagnostic strategies for mutations of the calcium-sensing receptor gene: application to a large cohort of patients with different hypercalcemic syndromes. Journal of Bone and Mineral Research 23 423.
16. He N, Zahirieh A, Mei Y, Lee B, Senthilnathan S, Wong B, Mucha B, Hildebrandt F, Cole DEC, Cattran D et al. 2007 Recessive NPHS2 (podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. Clinical Journal of the American Society of Nephrology 2 31-37.
17. Heath H III, Odelberg S, Jackson CE, Teh BT, Hayward N, Larsson C, Buist NR, Krapcho KJ, Hung BC, Capuano IV et al. 1996 Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. Journal of Clinical Endocrinology and Metabolism 81 1312-1317.
18. Hendy GN & Cole DEC 2007 Parathyroid Disorders. In Emery and Rimoin's Principles and Practice of Medical Genetics 5th edition, vol 2 ch 89, pp 1951-1979. Eds DL Rimoin, JM Connor, RE Pyeritz & BE Korf. Edinburgh: Churchill Livingstone.
19. Hendy GN, D'Souza-Li L, Yang B, Canaff L & Cole DEC 2000 Mutation update, mutations in the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism and autosomal dominant hypocalcemia. Human Mutation 16 281-296.
20. Hendy GN, Minutti C, Canaff L, Pidasheva S, Yang B, Nouhi Z, Zimmerman D, Wei C & Cole DEC 2003 Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor gene. Journal of Clinical Endocrinology and Metabolism 88 3674-3681.
21. Houdayer C, Gauthier-Villars M, Lauge A, Pagès-Berhouet S, Dehainault C, Caux-Moncoutier V, Karczynski P, Tosi M, Doz E, Desjardins L et al. 2004 Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Human Mutation 23 193-202.
22. 2+-sensing receptor gene to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mammalian Genome 6 798-801.
23. Law WM & Heath H III 1985 Familial benign hypercalcemia (hypocalciuric hypercalcemia): clinical and pathogenetic study of 21 families. Annals of Internal Medicine 102 511-519.
24. Lenato GM, Lastella P, Di Giacomo MC, Resta N, Suppressa P, Pasculli G, Sabbà C & Guanti G 2006 DHPLC-based mutations analysis of ENG and ALK-1 genes in HHT Italian populations. Human Mutation 27 213-214.
25. Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RWJ & Lasker RD 1981 The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features of fifteen families. Medicine 60 397-412.
26. Ng PC & Henikoff S 2003 SIFT: predicting amino acid changes that affect protein function. Nuclear Receptor Signaling 31 3812-3814.
27. Oefner PJ & Underhill PA 1998 DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC). In Current Protocols in Human Genetics, vol 19:7.10.1-7.10.12, Eds NC Dracopoli, JL Haines, BR Korf, DT Moir, CC Morton, CE Seidman, JG Seidman & DR Smith. New York: Wiley & Sons.
28. Pearce SHS, Trump D, Wooding C, Besser GM, Chew S, Heath D, Hughes I & Thakker RV 1995 Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. The Journal of Clinical Investigation 96 2683-2692.
29. Pearce SHS, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P et al. 1996 A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. New England Journal of Medicine 335 1115-1122.
30. Pidasheva S, D'Souza-Li L, Canaff L, Cole DEC & Hendy GN 2004 CASRdb, calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism and autosomal dominant hypocalcemia. Human Mutation 24 107-111.
31. Pidasheva S, Grant M, Canaff L, Ercan O, Kumar U & Hendy GN 2006 The calcium-sensing receptor (CASR) dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of novel CASR mutations causing familial hypocalciuric hypercalcemia. Human Molecular Genetics 15 2200-2209.
32. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75 1297-1303.
33. 2+-sensing receptor gene mutation. Nature Genetics 8 303-307.
34. Ramensky V, Bork P & Sunyaev S 2002 Human non-synonymous SNPs: server and survey. Nuclear Receptor Signaling 30 3894-3900.
35. Schollen E, Dequeker E, McQuaid S, Vankeirsbilck B, Michils G, Harvey J, van den Akker E, van Schooten R, Clark Z, Schrooten S et al. 2005 DDQA, Collaborative Group Diagnostic DHPLC Quality Assurance (DDQA): a collaborative approach to the generation of validated and standardized methods for DHPLC-based mutation screening in clinical genetics laboratories. Human Mutation 25 583-592.
36. Scillitani A, Guarnieri V, De Geronimo S, Muscarella LA, Battista C, D'Agruma L, Bertoldo F, Florio C, Minisola S, Hendy GN et al. 2004 Blood ionized calcium is associated with clustered polymorphisms in the carboxy-terminal tail of the calcium-sensing receptor. Journal of Clinical Endocrinology and Metabolism 89 5634-5638.
37. Sellner LN & Taylor GR 2004 MLPA and MAPH: new techniques for detection of gene deletions. Human Mutation 23 413-419.
38. Sunyaev S, Ramensky V, Koch I, Lathe W III, Kondrashov AS & Bork P 2001 Prediction of deleterious human alleles. Human Molecular Genetics 10 591-597.
39. Tchernitchko D, Goossens M& Wajcmen H 2004 Insilico prediction of the deleterious effect of a mutation: proceed with caution in clinical genetics. Clinical Chemistry 50 1974-1978.
40. Waller S, Kurzawinski T, Spitz L, Thakker R, Cranston T, Pearce S, Cheetham T & van't Hoff WG 2004 Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. European Journal of Pediatrics 163 589-594.
41. Xiao W & Oefner PJ 2001 Denaturing high-performance liquid chromatography: A review. Human Mutation 17 439-474.
42. Yun FHJ, Wong BYL, Chase M, Shuen AY, Canaff L, Thongthai K, Siminovitch K, Hendy GN & Cole DEC 2007 Genetic variation at the calcium-sensing receptor (CASR) locus: Implications for clinical molecular diagnostics. Clinical Biochemistry 40 551-561.